pharmorx.com valuation and analysis

Robots.txt Information
Robot Path Permission
GoogleBot /
BingBot /
BaiduSpider /
YandexBot /
User-agent: * Allow: / # Optimization for Google Ads Bot User-agent: AdsBot-Google-Mobile User-agent: AdsBot-Google Disallow: /_api/* Disallow: /_partials* Disallow: /pro-gallery-webapp/v1/galleries/* # Block PetalBot User-agent: PetalBot Disallow: / Sitemap: https://www.pharmorx.com/sitemap.xml # Auto generated, go to SEO Tools > Robots.txt Editor to change
Meta Tags
Title PharmoRx Therapeutics, Inc. | Westborough, MA | Low Dose
Description PRODUCT Our mission at PharmoRx Therapeutics is to create therapies for treating dopamine-related central nervous system diseases. We believe that we have found therapies for treatment resistant depression, impulsive compulsive disorders, depression in
Keywords central nervous system diseases, enhanced dopamine signaling, impulsive compulsive disorders, low dose naltrexone
Server Information
WebSite pharmorx faviconpharmorx.com
Host IP 23.236.62.147
Location United States
Related Websites
Site Rank
More to Explore
pharmorx.com Valuation
US$534,774
Last updated: 2023-05-17 23:14:37

pharmorx.com has Semrush global rank of 19,792,126. pharmorx.com has an estimated worth of US$ 534,774, based on its estimated Ads revenue. pharmorx.com receives approximately 61,705 unique visitors each day. Its web server is located in United States, with IP address 23.236.62.147. According to SiteAdvisor, pharmorx.com is safe to visit.

Traffic & Worth Estimates
Purchase/Sale Value US$534,774
Daily Ads Revenue US$494
Monthly Ads Revenue US$14,810
Yearly Ads Revenue US$177,710
Daily Unique Visitors 4,114
Note: All traffic and earnings values are estimates.
DNS Records
Host Type TTL Data
pharmorx.com. A 21599 IP: 23.236.62.147
pharmorx.com. NS 21600 NS Record: dns101.register.com.
pharmorx.com. NS 21600 NS Record: dns102.register.com.
pharmorx.com. MX 21600 MX Record: 5 alt1.aspmx.l.google.com.
pharmorx.com. MX 21600 MX Record: 5 alt2.aspmx.l.google.com.
pharmorx.com. MX 21600 MX Record: 10 aspmx3.googlemail.com.
pharmorx.com. MX 21600 MX Record: 10 aspmx.l.google.com.
pharmorx.com. MX 21600 MX Record: 10 aspmx2.googlemail.com.
pharmorx.com. TXT 21600 TXT Record: google-site-verification=lgAOawVh_gOoiuGVNumeSlWtqcmE45lL04Mvy23-CDg
HtmlToTextCheckTime:2023-05-17 23:14:37
top of page HOME ABOUT PRODUCT PLATFORM TEAM CONTACT Low Dose Naltrexone for Enhanced Dopamine Signaling ​ PharmoRx Therapeutics’ patented method for improving dopamine signaling involves the use of low dose naltrexone (LDN) in combination with widely prescribed dopamine-related medications that are currently being used to treat a variety of central nervous system diseases, such as restless leg syndrome (RLS) and treatment resistant depression (TRD). We believe that our discovery provides us with a platform for enhanced therapies for RLS and TRD, as well as a number of impulsive compulsive disorders such as binge eating disorders and cocaine addiction. ​ ​ Clinical Studies to Date O ur first study was performed to test the improved efficacy of a dopamine agonist for RLS by adding a low dose of the well characterized opioid antagonist, naltrexone, with the leading dopamimetics. The result of this study was quite impressive, showing that the small number of patients were able to achieve
HTTP Headers
HTTP/1.1 301 Moved Permanently
Date: Wed, 27 Apr 2022 08:26:16 GMT
Content-Length: 0
Connection: keep-alive
location: https://www.pharmorx.com/
strict-transport-security: max-age=3600
Age: 64203
Server-Timing: cache;desc=hit, varnish;desc=hit, dc;desc=uw2-pub-1
X-Seen-By: gv/XVF9HsGpk8A2KWukUzCWfEJXUOf1J0Ah0dFlolkk=,GXNXSWFXisshliUcwO20Naon851uhK6HRsxREnrEO9aDaqyfD+CMw0d/iuvzTEDXmuOkfcTSJaUOHlD2KQbqrA==,m0j2EEknGIVUW/liY8BLLniEmx2jdHh/ZlXwZ6LpuGEG/hKs8AeY1T4OIbgnD+yx,2d58ifebGbosy5xc+FRalriz/MPvuVfv1Xkk6kYmhhxHIUm1ZHrAqZ3SrZSZT8Hk0Zx94WlSIHMu1syRZkCf1A==,2UNV7KOq4oGjA5+PKsX47BChUuzMvEKHAre8Xn85A0QR2rxCTgaJ7/K2Kx9jhAfC
Cache-Control: no-cache
X-Wix-Request-Id: 1651047976.607360467119120090
X-Content-Type-Options: nosniff

HTTP/2 200 
date: Wed, 27 Apr 2022 08:26:17 GMT
content-type: text/html; charset=UTF-8
link: ; rel=preconnect; crossorigin;,; rel=preconnect;,; rel=preconnect; crossorigin;,; rel=preconnect; crossorigin;,; rel=preconnect;,; rel=preconnect; crossorigin;,
x-wix-request-id: 1651047977.0612146805212193
content-language: en
strict-transport-security: max-age=3600
age: 0
set-cookie: ssr-caching=cache#desc=miss#varnish=miss#dc#desc=euw3; Max-Age=20; Expires=Wed, 27 Apr 2022 08:26:37 GMT
server-timing: cache;desc=miss, varnish;desc=miss, dc;desc=euw3
x-seen-by: sHU62EDOGnH2FBkJkG/Wx8EeXWsWdHrhlvbxtlynkVgErLMcFovb2LGyGiwoZzXs,qquldgcFrj2n046g4RNSVFHX+9pl0hogZJEnMG0iIcI=,2d58ifebGbosy5xc+FRall4mlymtxoby1NRjcqafl17eObAjdd1kSxlXE/l4YTrljoe2GMQJ/MdiMK4Y/vI70zmlk8pnk9Fjx4fGtxDFbzA=,2UNV7KOq4oGjA5+PKsX47CK4wJ01aY3ZbqTi7BzxQjE=,7npGRUZHWOtWoP0Si3wDpzoVfoVUNO1+IT+lafZOIGw=,0roNRkh2xJh7V8AO49Mmo4aBI9HfdgEXMFRPq8BaC3WHWVBwzdKgeyBwf5Xy6KjsWIHlCalF7YnfvOr2cMPpyw==,xTu8fpDe3EKPsMR1jrheEDGGM7upC53PN9X6mGtdykU=,LoUK8/saGAmOxZWtpubo2nxCJA0fbhwSxwGigZZi9g3l1b4xYyiLo+n7Lotvc4x4Ru9WojE5M2QWmaA7+ew4GA==,xTu8fpDe3EKPsMR1jrheEFb9J9Li2KdiXY67vz8KTM4=,xTu8fpDe3EKPsMR1jrheEJ/42kstuu7WIH0tcndVk0k=,/a5ccLSK1HEmwPNg/x6Ous8YtXfhXLw/W9VRXxvJ9eEoi8hjcL5YUH4bb/Wruc3dp/aKdfYLA6Xb9M2kDqBPjw==
cache-control: no-cache
vary: Accept-Encoding
accept-ranges: bytes
x-content-type-options: nosniff
server: Pepyaka/1.19.10
pharmorx.com Whois Information
Domain Name: PHARMORX.COM
Registry Domain ID: 166656998_DOMAIN_COM-VRSN
Registrar WHOIS Server: whois.register.com
Registrar URL: http://www.register.com
Updated Date: 2021-03-15T15:12:06Z
Creation Date: 2005-06-07T14:47:21Z
Registry Expiry Date: 2022-06-07T14:47:21Z
Registrar: Register.com, Inc.
Registrar IANA ID: 9
Registrar Abuse Contact Email: abuse@web.com
Registrar Abuse Contact Phone: +1.8003337680
Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited
Name Server: DNS101.REGISTER.COM
Name Server: DNS102.REGISTER.COM
DNSSEC: unsigned
>>> Last update of whois database: 2022-04-27T09:04:34Z <<<